Shanghai ZJ Bio-Tech Co. Ltd. A (688317) — Net Asset Quality Index
Shanghai ZJ Bio-Tech Co. Ltd. A (688317) has a Net Asset Quality Index of 89.2% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥3.66 Billion minus total liabilities of CN¥395.66 Million yields net assets of CN¥3.26 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Read 688317 total debt and obligations for a breakdown of total debt and financial obligations.
Quality Index
Net Assets
Total Assets
Total Liabilities
Shanghai ZJ Bio-Tech Co. Ltd. A Net Asset Quality Index Over Time (2013–2025)
This chart shows how Shanghai ZJ Bio-Tech Co. Ltd. A's Net Asset Quality Index has evolved across 13 annual periods from 2013 to 2025. As of June 2026, the index stands at 89.2%, representing net assets of CN¥3.26 Billion against total assets of CN¥3.66 Billion CNY. For live market cap and overall valuation, see 688317 company net worth.
Annual Net Asset Quality Index for Shanghai ZJ Bio-Tech Co. Ltd. A (2013–2025)
The table below presents the year-by-year Net Asset Quality Index for Shanghai ZJ Bio-Tech Co. Ltd. A from 2013 to 2025, covering 13 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. See Shanghai ZJ Bio-Tech Co. Ltd. A (688317) net assets for net asset value and shareholders' equity analysis.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 89.0% | CN¥3.35 Billion | CN¥3.76 Billion | CN¥414.95 Million | ▼ -7.0 pp |
| 2024 | 96.0% | CN¥3.64 Billion | CN¥3.79 Billion | CN¥153.06 Million | ▲ +2.1 pp |
| 2023 | 93.9% | CN¥3.82 Billion | CN¥4.07 Billion | CN¥249.25 Million | ▲ +5.3 pp |
| 2022 | 88.5% | CN¥4.20 Billion | CN¥4.74 Billion | CN¥543.44 Million | ▼ -1.4 pp |
| 2021 | 90.0% | CN¥3.83 Billion | CN¥4.25 Billion | CN¥427.27 Million | ▲ +12.1 pp |
| 2020 | 77.8% | CN¥1.46 Billion | CN¥1.88 Billion | CN¥416.97 Million | ▼ -11.3 pp |
| 2019 | 89.1% | CN¥571.84 Million | CN¥641.93 Million | CN¥70.09 Million | ▼ -2.8 pp |
| 2018 | 91.9% | CN¥532.66 Million | CN¥579.64 Million | CN¥46.98 Million | ▲ +0.3 pp |
| 2017 | 91.6% | CN¥472.70 Million | CN¥516.12 Million | CN¥43.42 Million | ▼ -0.3 pp |
| 2016 | 91.9% | CN¥483.90 Million | CN¥526.57 Million | CN¥42.66 Million | ▲ +4.8 pp |
| 2015 | 87.1% | CN¥343.47 Million | CN¥394.29 Million | CN¥50.82 Million | ▲ +31.8 pp |
| 2014 | 55.3% | CN¥110.35 Million | CN¥199.63 Million | CN¥89.28 Million | ▼ -14.2 pp |
| 2013 | 69.5% | CN¥118.03 Million | CN¥169.78 Million | CN¥51.75 Million | — |